1-17 of 17
James C. Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT572: Phase 1b dose-escalation and dose-expansion study evaluating trastuzumab deruxtecan (T-DXd) in combination with durvalumab and cisplatin, carboplatin, or pemetrexed in advanced or metastatic, HER2-overexpressing, nonsquamous non-small cell lung cancer (NSCLC): DESTINY-Lung03

Free
David Planchard, Julie R. Brahmer, James C. Yang, Yuh-Min Chen, Kang-Yun Lee, Thatthan Suksombooncharoen, Natasha Viglianti, Mark Gustavson, Alejandra Ragone, Amaya Gasco Hernandez
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT572.
https://doi.org/10.1158/1538-7445.AM2022-CT572
Published: 15 June 2022
View articletitled, Abstract CT572: Phase 1b dose-escalation and dose-expansion study evaluating trastuzumab deruxtecan (T-DXd) in combination with durvalumab and cisplatin, carboplatin, or pemetrexed in advanced or metastatic, HER2-overexpressing, nonsquamous non-small cell lung cancer (NSCLC): DESTINY-Lung03
Journal Articles

Abstract 127: Single cell mapping of tumor infiltrating lymphocytes enables neoantigen-reactive T cell identification in metastatic human cancer

Free
Frank J. Lowery, Sri Krishna, Rami Yossef, Praveen D. Chatani, Neilesh B. Parikh, Yong-Chen Lu, Nikolaos Zacharakis, Noam Levin, Ken-ichi Hanada, James C. Yang, Paul F. Robbins, Maria R. Parkhurst, Steven A. Rosenberg
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 127.
https://doi.org/10.1158/1538-7445.AM2021-127
Published: 01 July 2021
View articletitled, Abstract 127: Single cell mapping of tumor infiltrating lymphocytes enables neoantigen-reactive T cell identification in metastatic human cancer
Journal Articles

Abstract 273: A mass spectrometry survey of frequent HLA alleles successfully presenting common tumor specific mutations for immune recognition

Free
Catherine M. Ade, Yue A. Qi, Sudipto Das, Ken-ichi Hanada, Tapan Maity, Xu Zhang, Thorkell Andresson, Udayan Guha, James C. Yang
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 273.
https://doi.org/10.1158/1538-7445.AM2021-273
Published: 01 July 2021
View articletitled, Abstract 273: A mass spectrometry survey of frequent HLA alleles successfully presenting common tumor specific mutations for immune recognition
Journal Articles

Abstract LB-242: Identification of T-cell receptors targeting KRAS-mutated human tumors

Free
Qiong J. Wang, Zhiya Yu, Kenichi Hanada, Nicholas P. Restifo, James C. Yang
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): LB-242.
https://doi.org/10.1158/1538-7445.AM2016-LB-242
Published: 15 July 2016
View articletitled, Abstract LB-242: Identification of T-cell receptors targeting KRAS-mutated human tumors
Journal Articles

Abstract CT003: A phase I study of an HLA-DPB1*0401-restricted T-cell receptor targeting MAGE-A3 for patients with metastatic cancer

Free
Yong-Chen Lu, Linda L. Parker, Tangying Lu, Zhili Zheng, Xin Yao, Paul F. Robbins, Steven A. Feldman, Pierre van der Bruggen, Christopher A. Klebanoff, Christian S. Hinrichs, Stephanie L. Goff, Richard M. Sherry, Udai S. Kammula, James C. Yang, Steven A. Rosenberg
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): CT003.
https://doi.org/10.1158/1538-7445.AM2016-CT003
Published: 15 July 2016
View articletitled, Abstract CT003: A phase I study of an HLA-DPB1*0401-restricted T-cell receptor targeting MAGE-A3 for patients with metastatic cancer
Journal Articles

Abstract IA18: Adoptive T-cell transfer for metastatic melanoma: What are the relevant antigens?

Free
James C. Yang
Journal: Cancer Research
Cancer Res (2015) 75 (14_Supplement): IA18.
https://doi.org/10.1158/1538-7445.MEL2014-IA18
Published: 16 July 2015
View articletitled, Abstract IA18: Adoptive T-cell transfer for metastatic melanoma: What are the relevant antigens?
Journal Articles

Abstract IA18: T cell adoptive therapy for cancer: Translating the science.

Free
James C. Yang
Journal: Cancer Research
Cancer Res (2013) 73 (1_Supplement): IA18.
https://doi.org/10.1158/1538-7445.TUMIMM2012-IA18
Published: 02 April 2014
View articletitled, Abstract IA18: T cell adoptive therapy for cancer: Translating the science.
Journal Articles

Distinctive Features of the Differentiated Phenotype and Infiltration of Tumor-Reactive Lymphocytes in Clear Cell Renal Cell Carcinoma

Free
Qiong J. Wang, Ken-ichi Hanada, Paul F. Robbins, Yong F. Li, James C. Yang
Journal: Cancer Research
Cancer Res (2012) 72 (23): 6119–6129.
https://doi.org/10.1158/0008-5472.CAN-12-0588
Published: 29 November 2012
View articletitled, Distinctive Features of the Differentiated Phenotype and Infiltration of Tumor-Reactive Lymphocytes in Clear Cell Renal Cell Carcinoma
Open the PDF for Distinctive Features of the Differentiated Phenotype and Infiltration of Tumor-Reactive Lymphocytes in Clear Cell Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 3725: Combined cytotoxic effects of volasertib and cisplatin in urothelial carcinoma cells

Free
Chia-Chi Lin, Yu-Mine Lin, Yu-Chieh Tsai, Yeong-Shiau Pu, Ann-Lii Cheng, James C. Yang
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3725.
https://doi.org/10.1158/1538-7445.AM2012-3725
Published: 15 April 2012
View articletitled, Abstract 3725: Combined cytotoxic effects of volasertib and cisplatin in urothelial carcinoma cells
Journal Articles

Abstract LB-175: Tumor regression in patients with metastatic synovial sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

Free
Robbins F. Paul, Richard A. Morgan, Steven A. Feldman, James C. Yang, Mark E. Dudley, Yong F. Li, Mona El-Gamil, Susan L. Schwarz, Steven A. Rosenberg
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): LB-175.
https://doi.org/10.1158/1538-7445.AM10-LB-175
Published: 15 April 2010
View articletitled, Abstract LB-175: Tumor regression in patients with metastatic synovial sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1
Journal Articles

Characterization of a novel non-classical CD4+ clone with broad reactivity against human renal cell carcinomas (RCCs)

Free
Qiong J. Wang, Ken-Ichi Hanada, James C. Yang
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 909.
Published: 15 April 2006
View articletitled, Characterization of a novel non-classical CD4+ clone with broad reactivity against human renal cell carcinomas (RCCs)
Journal Articles

Immunization against Endogenous Retroviral Tumor-associated Antigens

Free
Michael H. Kershaw, Cary Hsu, Wallace Mondesire, Libbie L. Parker, Gang Wang, Willem W. Overwijk, Rejean Lapointe, James C. Yang, Rong-Fu Wang, Nicholas P. Restifo, Patrick Hwu
Journal: Cancer Research
Cancer Res (2001) 61 (21): 7920–7924.
Published: 01 November 2001
View articletitled, Immunization against Endogenous Retroviral Tumor-associated Antigens
Open the PDF for Immunization against Endogenous Retroviral Tumor-associated Antigens in another window
Journal Articles

Identification of Fibroblast Growth Factor-5 as an Overexpressed Antigen in Multiple Human Adenocarcinomas

Free
Ken-ichi Hanada, Donna M. Perry-Lalley, Galen A. Ohnmacht, Maria P. Bettinotti, James C. Yang
Journal: Cancer Research
Cancer Res (2001) 61 (14): 5511–5516.
Published: 01 July 2001
View articletitled, Identification of Fibroblast Growth Factor-5 as an Overexpressed Antigen in Multiple Human Adenocarcinomas
Open the PDF for Identification of Fibroblast Growth Factor-5 as an Overexpressed Antigen in Multiple Human Adenocarcinomas in another window
Journal Articles

Costimulation Enhances the Active Immunotherapy Effect of Recombinant Anticancer Vaccines

Free
Ronald S. Chamberlain, Miles W. Carroll, Vincenzo Bronte, Patrick Hwu, Steven Warren, James C. Yang, Michael Nishimura, Bernard Moss, Steven A. Rosenberg, Nicholas P. Restifo
Journal: Cancer Research
Cancer Res (1996) 56 (12): 2832–2836.
Published: 01 June 1996
View articletitled, Costimulation Enhances the Active Immunotherapy Effect of Recombinant Anticancer Vaccines
Open the PDF for Costimulation Enhances the Active Immunotherapy Effect of Recombinant Anticancer Vaccines in another window
Journal Articles

Minimal Determinant Expressed by a Recombinant Vaccinia Virus Elicits Therapeutic Antitumor Cytolytic T Lymphocyte Responses

Free
Barbra Jill McCabe, Kari R. Irvine, Michael I. Nishimura, James C. Yang, Paul J. Spiess, Eliza P. Shulman, Steven A. Rosenberg, Nicholas P. Restifo
Journal: Cancer Research
Cancer Res (1995) 55 (8): 1741–1747.
Published: 01 April 1995
View articletitled, Minimal Determinant Expressed by a Recombinant Vaccinia Virus Elicits Therapeutic Antitumor Cytolytic T Lymphocyte Responses
Open the PDF for Minimal Determinant Expressed by a Recombinant Vaccinia Virus Elicits Therapeutic Antitumor Cytolytic T Lymphocyte Responses in another window
Journal Articles

Mechanisms of Adoptive Immunotherapy: Improved Methods for in Vivo Tracking of Tumor-infiltrating Lymphocytes and Lymphokine-activated Killer Cells

Free
Paul K. Wallace, Larry D. Palmer, Donna Perry-Lalley, Ellen S. Bolton, Richard B. Alexander, Paul K. Horan, James C. Yang, Katharine A. Muirhead
Journal: Cancer Research
Cancer Res (1993) 53 (10): 2358–2367.
Published: 01 May 1993
View articletitled, Mechanisms of Adoptive Immunotherapy: Improved Methods for in Vivo Tracking of Tumor-infiltrating Lymphocytes and Lymphokine-activated Killer Cells
Open the PDF for Mechanisms of Adoptive Immunotherapy: Improved Methods for in Vivo Tracking of Tumor-infiltrating Lymphocytes and Lymphokine-activated Killer Cells in another window
Journal Articles

Combined Effects of Chemotherapy and Interleukin 2 in the Therapy of Mice with Advanced Pulmonary Tumors

Free
Moshe Z. Papa, James C. Yang, John T. Vetto, Eitan Shiloni, Avi Eisenthal, Steven A. Rosenberg
Journal: Cancer Research
Cancer Res (1988) 48 (1): 122–129.
Published: 01 January 1988
View articletitled, Combined Effects of Chemotherapy and Interleukin 2 in the Therapy of Mice with Advanced Pulmonary Tumors
Open the PDF for Combined Effects of Chemotherapy and Interleukin 2 in the Therapy of Mice with Advanced Pulmonary Tumors in another window